WITHDRAWN: Community Eye Health Intervention Trial Highlights Ongoing Access Challenges — Lessons for Australian Primary Care Integration

References

1. 1.Columbia University. (2024). Eye Health Intervention Study in Upper Manhattan. ClinicalTrials.gov. NCT06112431. https://clinicaltrials.gov/study/NCT06112431
2. 2.Flaxman, S. R., Bourne, R. R., Resnikoff, S., Ackland, P., Braithwaite, T., Cicinelli, M. V., Das, A., Jonas, J. B., Keeffe, J., Kempen, J. H., Leasher, J., Limburg, H., Naidoo, K., Pesudovs, K., Silvester, A., Stevens, G. A., Tahhan, N., Wong, T. Y., Taylor, H. R., & Vision Loss Expert Group of the Global Burden of Disease Study. (2017). Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. The Lancet Global Health, 5(12), e1221-e1234. https://doi.org/10.1016/S2214-109X(17)30393-5
3. 3.Glasgow, R. E., Vogt, T. M., & Boles, S. M. (1999). Evaluating the public health impact of health promotion interventions: the RE-AIM framework. American Journal of Public Health, 89(9), 1322-1327. https://doi.org/10.2105/AJPH.89.9.1322
4. 4.Tham, Y. C., Li, X., Wong, T. Y., Quigley, H. A., Aung, T., & Cheng, C. Y. (2014). Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology, 121(11), 2081-2090. https://doi.org/10.1016/j.ophtha.2014.05.013
5. 5.Weinreb, R. N., Aung, T., & Medeiros, F. A. (2014). The pathophysiology and treatment of glaucoma: a review. JAMA, 311(18), 1901-1911. https://doi.org/10.1001/jama.2014.3192
6. 6.World Health Organization. (2019). World report on vision. World Health Organization. WHO/NMH/NVI/19.1. https://www.who.int/publications/i/item/9789241516570
7. 7.Zhang, X., Kahende, J., Fan, A. Z., Barker, L., Thompson, T. J., Mokdad, A. H., Li, Y., & Saaddine, J. B. (2011). Barriers to eye care in the United States: geographic and demographic factors. Ophthalmic Epidemiology, 18(4), 172-181. https://doi.org/10.3109/09286586.2011.615774